Appointment booking for Dr. Kiyoko Tomita, MD is currently not available.Dr. Kiyoko Tomita, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Kiyoko Tomita, MD (she/her) is a Internist in Greenwich, CT with over 14 years of experience. What is your opinion of Dr. Kiyoko Tomita, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 14 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Kiyoko Tomita, MD has received over $1,243 which includes payments from the following companies:
$272.58 from GlaxoSmithKline, LLC.
$153.48 from Teva Pharmaceuticals USA, Inc.
$122.49 from AstraZeneca Pharmaceuticals LP
$81.17 from Daiichi Sankyo Inc.
$76.44 from Novartis Pharmaceuticals Corporation
$74.89 from LILLY USA, LLC
$68.95 from Purdue Pharma L.P.
$57.09 from E.R. Squibb & Sons, L.L.C.
$44.26 from Astellas Pharma US Inc
$38.81 from Celgene Corporation
$36.58 from Novo Nordisk Inc
$30.67 from VIVUS, Inc.
$29.14 from XenoPort Inc.
$25.17 from Medtronic Vascular, Inc.
$24.14 from sanofi-aventis U.S. LLC
$23.68 from Eisai Inc.
$18.29 from Actavis Pharma Inc
$16.94 from Salix Pharmaceuticals, Ltd
$15.79 from Allergan Inc.
$11.87 from Mylan Pharmaceuticals Inc.
Payments received by Dr. Kiyoko Tomita, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!